NasdaqGS - Delayed Quote • USD
QuidelOrtho Corporation (QDEL)
At close: April 23 at 4:00 PM EDT
After hours: April 23 at 4:20 PM EDT
Earnings Estimate
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 7 | 7 | 7 | 7 |
| Avg. Estimate | 0.52 | 0.02 | 2.4 | 3.72 |
| Low Estimate | 0.25 | -0.25 | 1.8 | 2.87 |
| High Estimate | 0.74 | 0.21 | 2.77 | 4.87 |
| Year Ago EPS | 1.8 | 0.26 | 4.13 | 2.4 |
Revenue Estimate
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 7 | 7 | 7 | 7 |
| Avg. Estimate | 700.14M | 643.76M | 2.79B | 2.9B |
| Low Estimate | 681.9M | 632.17M | 2.72B | 2.75B |
| High Estimate | 734.42M | 661M | 2.86B | 2.99B |
| Year Ago Sales | 794.05M | 615.16M | 3B | 2.79B |
| Sales Growth (year/est) | -11.80% | 4.60% | -7.10% | 4.30% |
Earnings History
| CURRENCY IN USD | 3/31/2023 | 6/30/2023 | 9/30/2023 | 12/31/2023 |
|---|---|---|---|---|
| EPS Est. | 1.49 | 0.28 | 0.6 | 2.05 |
| EPS Actual | 1.8 | 0.26 | 0.9 | 1.17 |
| Difference | 0.31 | -0.02 | 0.3 | -0.88 |
| Surprise % | 20.80% | -7.10% | 50.00% | -42.90% |
EPS Trend
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | 0.52 | 0.02 | 2.4 | 3.72 |
| 7 Days Ago | 0.58 | 0.05 | 2.46 | 3.92 |
| 30 Days Ago | 0.74 | 0.15 | 2.59 | 3.88 |
| 60 Days Ago | 0.7 | 0.14 | 2.56 | 3.95 |
| 90 Days Ago | 1.49 | 0.62 | 5.07 | 5.99 |
EPS Revisions
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | 1 | -- | -- | 1 |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | 1 | 1 | 1 | 1 |
Growth Estimates
| CURRENCY IN USD | QDEL | Industry | Sector | S&P 500 |
|---|---|---|---|---|
| Current Qtr. | -71.10% | -- | -- | 0.40% |
| Next Qtr. | -92.30% | -- | -- | 9.90% |
| Current Year | -41.90% | -- | -- | 4.30% |
| Next Year | 55.00% | -- | -- | 13.40% |
| Next 5 Years (per annum) | 7.20% | -- | -- | 11.09% |
| Past 5 Years (per annum) | 8.43% | -- | -- | -- |
Research Analysis
Upgrades & Downgrades
| Downgrade | UBS: Neutral to Sell | 3/4/2024 |
| Downgrade | Craig-Hallum: Buy to Hold | 2/14/2024 |
| Maintains | RBC Capital: Outperform to Outperform | 2/14/2024 |
| Downgrade | Raymond James: Strong Buy to Outperform | 2/14/2024 |
| Downgrade | William Blair: Outperform to Market Perform | 2/14/2024 |
| Downgrade | JP Morgan: Neutral to Underweight | 2/14/2024 |
Related Tickers
NARI Inari Medical, Inc.
37.11
-2.16%
BIO Bio-Rad Laboratories, Inc.
285.28
+1.84%
CNMD CONMED Corporation
71.31
-1.79%
IART Integra LifeSciences Holdings Corporation
29.38
+1.38%
PODD Insulet Corporation
167.27
+1.73%
NVCR NovoCure Limited
12.06
+1.90%
INSP Inspire Medical Systems, Inc.
233.93
+3.87%
BRKR Bruker Corporation
82.46
+5.65%
IRTC iRhythm Technologies, Inc.
116.34
+2.39%
PACB Pacific Biosciences of California, Inc.
1.4700
-5.77%